System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Piergiacomo Calzavara-Pinton is an expert in Dermatology at Spedali Civili di Brescia (Italy). As of October 2026, ScienceLeadR ranks Piergiacomo Calzavara-Pinton in the top 1% of experts worldwide for Keratosis, Dermatitis and Sexually Transmitted Diseases. Piergiacomo Calzavara-Pinton has authored 494 publications, the most recent in 2026, and is an investigator in 9 clinical trials, 2 of them ongoing. SLR score: 1,597 (community average: 125). How the SLR is computed.

LeadR Profile

Piergiacomo Calzavara-Pinton Spedali Civili di Brescia Italy
1 597 ScienceLeadR Reputation 1597

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Public Health - Immunology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Biography:

Piergiacomo Calzavara-Pinton, MD, is Full Professor and Chair of the Department of Dermatology and School of Specialization of Dermatology at the University and ASST-Spedali Civili of Brescia, Italy. His clinical and research interests focus on photo-dermatology, non invasive diagnostic techniques, inflammatory diseases and skin oncology. He is the head of a team working on the development of new drugs for the treatment of skin tumors and inflammatory disorders, new photoprotective and photosensitizing molecules and innovative non-invasive diagnostic techniques. He has a teaching role in the PhD program of Artificial Intelligence in Medicine of the University of Brescia that is trying to shape new perspectives in teaching and care in Medicine.

Author and co Author of 502 papers cited on Scopus. H-index 59.

President of the European Society of Photodermatology and EADV Task force on Photodermatology. Past Board Member of the European Academy of Dermatology and Venereology. President Emeritus of the Italian Society of Dermatology and STDs. Honorary Member Italian, Austrian, French and Swiss National Societies of Dermatology.


Organizations

Career arc: 1987 - 2026
Source: PubMed

Spedali Civili di Brescia

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 494

Citations

Citations: 10 969 1st author: 91 Last author: 136 Unique author: 6

Main journals

J Eur Acad Dermatol Venereol 58
G Ital Dermatol Venereol 56
Br J Dermatol 27
Ital J Dermatol Venerol 23
J Am Acad Dermatol 20

Best Journals

N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Efficacy and Safety of Delgocitinib and Its Impact on Patient's Perspective for Moderate-to-severe Chronic Hand Eczema in Adults: A 16-week Real-world Prospective Multicentre Study.
PMID 42839349 — sexually transmitted diseases, safety, eczema, dermatology		Acta Derm Venereol20260
Line-Field Confocal Optical Coherence Tomography in the Diagnosis of Fibrous Papules of the Nose: Diagnostic Insights From a Case Series.
PMID 42686640 — tomography, tomography, optical coherence, diagnosis, nose, dermatology, skin neoplasms		Australas J Dermatol20260
Organization of skin ulcer outpatient clinics in Italy: results from a survey of the Study Group on Ulcers of the Italian Society of Dermatology and Venereology.
PMID 42644840 — skin, skin ulcer, nursing, ambulatory care facilities, ulcer, skin diseases, outpatients, dermatology, venereology		Ital J Dermatol Venerol20260
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.
PMID 42605165 — quality of life, syphilis, vitiligo, therapeutics, dermatology, mental health		Br J Dermatol20260
Knowledge of chronic spontaneous urticaria management among Italian general practitioners: Baseline findings from the BRIDGE study.
PMID 42256025 — general practitioners, urticaria, diagnosis, education		World Allergy Organ J20260

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 4
Phase 3 4
Phase 2 1

By status:

Completed 4
Active not recruiting 3
Recruiting 1
Unknown 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 6

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase 3 Multicenter Randomized Double blind Placebo controlled and Deucravacitinib Active Comparator controlled Study to Evaluate the Efficacy and Safety of JNJ 77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
2023-507039-39-00 — safety, therapeutics, psoriasis		Phase 3Active not recruiting2024
Selective Treatment of Oral Povorcitinib in Vitiligo Study 2 (STOP V2)
2023-506011-18-00 — safety, vitiligo, therapeutics		Phase 3Active not recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS